ӳ����ý

A new adenine base editor expands the range of genetic sites that can be edited in human cells, with speed and efficiency far surpassing the original editor.

Tests that look for hundreds of tumor mutations in blood samples could one day be used to detect residual disease in patients after treatment.

Studying mumps virus genomes in 2016 and 2017 filled in gaps about how the disease was spreading in Massachusetts and elsewhere in the US.

Using a single-needle biopsy and new technology for tumor diagnosis, researchers provide a more detailed window into cancer biology, tumor type, and mechanisms of therapy response and resistance

Two studies in mice reveal a cellular circuit that inhibits inflammation in the intestine and lungs.

Partnership supports groundbreaking science through critical early stages of drug discovery

“Prime editing” combines two key proteins and a new RNA to make targeted insertions, deletions, and all possible single-letter changes in the DNA of human cells

Researchers harness Cas13 as an antiviral and diagnostic for RNA-based viruses

Hundreds of thousands of colon cells offer new clues into what goes wrong in an inflammatory bowel disease and why some patients don’t respond to drugs